Retatrutide (LY-3437943): Eli Lilly Retatrutide is a biologic entity that acts as a triagonist for the gastric inhibitory polypeptide (GIP) receptor, the GLP-1 receptor and the glucagon receptor
Most get through it within two weeks
Because tirzepatide engages two incretin pathways, it is technically distinct from single-receptor GLP-1 receptor agonists, even though it is commonly discussed alongside them
TrimRX recognizes these challenges and provides practical solutions to improve access to these medications
PlexusDx Precision Peptide Genetic Test identifies variants in FTO and MC4R, and GIPR genes plus 45 additional peptide genes that correlate with metabolic rate, appetite signaling, and lipid processing
Any changes are indirect results of weight loss, metabolic improvements, or medication side effects